SGLT2 Inhibitors Lower Mortality Risk Post-UTI in Diabetes
Recent research indicates that patients with type 2 diabetes who use SGLT2 inhibitors after a urinary tract infection have a lower mortality risk compared to those using DPP-4 inhibitors.
Posted inAI Medical News news Specialties
Oracle Health Launches AI-First, Voice-Enabled EHR to Enhance Clinician Experience and Compete with Epic
Oracle Health unveils a next-generation AI-powered, voice-first electronic health record (EHR) system designed from the ground up to improve clinical workflow and challenge Epic’s market dominance in the U.S. acute care sector.
Posted inAI news Specialties
10 Ways AI is Transforming Healthcare
Explore how AI is revolutionizing healthcare by enhancing diagnostics, predicting diseases, and supporting medical professionals in various capacities.
Posted inAI Gastroenterology news Specialties
AI in Colonoscopy: Enhancing Detection or Eroding Physician Skills?
The integration of AI in colonoscopy improves adenoma detection but raises concerns about declining physician skills when AI support is withdrawn, highlighting a potential clinical 'de-skilling' effect.
Posted inAI Cardiology news Specialties
Leveraging AI-Driven Care to Significantly Reduce Heart Failure Readmissions: The Linea Model
Linea integrates generative AI and high-touch virtual nursing to proactively manage heart failure patients, achieving a 50% reduction in hospital readmissions within 90 days, substantially lowering costs and improving patient outcomes.
Survey on Artificial Intelligence Adoption in the US Healthcare Sector: Trends, Challenges, and Future Directions
A comprehensive survey of 233 US healthcare systems reveals widespread AI deployment with key barriers including cost and resource limitations; highlights the critical role of CFOs and CIOs in AI decision-making and the growing influence of integrated EHR systems.
Posted innews
It’s Melanoma — Here’s What to Do Next
Understand melanoma, its signs, and the importance of early detection and testing to combat skin cancer effectively.
Posted innews Psychiatry Specialties
Illinois Takes a Stand Against AI in Mental Health Therapy
Illinois has enacted legislation banning AI chatbots for mental health therapy, joining Utah and Nevada in addressing concerns over AI's impact on vulnerable populations.
Posted inNeurology news Specialties
Enhancing Exercise Capacity Through Non-Invasive Vagus Nerve Stimulation: Evidence from a Randomized Controlled Trial
A randomized trial demonstrates that non-invasive transcutaneous vagus nerve stimulation improves peak oxygen uptake and exercise performance in healthy volunteers, highlighting its potential as a safe and scalable method to boost cardiorespiratory fitness.
Posted inCardiology news Specialties
Anaemia as a Predictor of Iron Dysregulation and Modulator of Empagliflozin Response in Heart Failure with Reduced Ejection Fraction: Insights from the EMPATROPISM-FE Trial
In patients with heart failure and reduced ejection fraction, anaemia predicts iron homeostasis disruption and influences response to empagliflozin, which increases myocardial iron and improves cardiac function and exercise capacity.
Posted inCardiology Clinical Updates Nephrology news Specialties
Delayed Remote Ischemic Preconditioning Reduces Contrast-Associated Acute Kidney Injury After Coronary Angiography and PCI: Insights from a Randomized Trial
A multicenter randomized trial demonstrates that delayed remote ischemic preconditioning 24 hours prior to coronary angiography or PCI significantly lowers the incidence of contrast-associated acute kidney injury in high-risk patients.
The Long-Term Legacy of Atorvastatin: Insights from the 20-Year ASCOT-Legacy Follow-Up
The ASCOT-Legacy study shows atorvastatin significantly reduces long-term cardiovascular events and deaths over 20 years in hypertensive patients, supporting early statin initiation for cardiovascular prevention.
Posted inCardiology news Specialties
Comparing Long-Term Outcomes of Biodegradable vs. Durable Polymer Everolimus-Eluting Stents in STEMI: Insights from the CONNECT Trial
The CONNECT trial demonstrates no significant difference in neoatherosclerosis rates 3 years post-STEMI between biodegradable and durable polymer everolimus-eluting stents, challenging assumptions about biodegradable polymers' superiority.
Posted inCardiology Clinical Updates news Specialties
Impact of Structural Cardiac Abnormalities on the Efficacy and Safety of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: Insights from the PARAGLIDE-HF Trial
The PARAGLIDE-HF trial demonstrates that sacubitril/valsartan significantly reduces NT-proBNP in patients with LVEF >40% and worsening heart failure, regardless of left ventricular hypertrophy or left atrial enlargement, but patients with both abnormalities face higher hyperkalemia risk.
Posted inCardiology Clinical Updates news Specialties
Empagliflozin’s Impact on Peripheral Microvascular Function in HFpEF: A Novel Vascular Insight
Empagliflozin alters peripheral microvascular responses in HFpEF patients, enhancing insulin-mediated vasodilation but reducing acetylcholine responsiveness, suggesting a targeted vascular mechanism distinct from general endothelial or smooth muscle effects.
Posted inCardiology Clinical Updates news Specialties
Enhancing Muscle Microvascular Function in Heart Failure: The Role of Acute BH4 Administration
Acute tetrahydrobiopterin (BH4) administration improves locomotor muscle microvascular function in heart failure patients, highlighting the nitric oxide pathway as a promising therapeutic target, while acute antioxidant therapy showed no benefit.
Posted inCardiology news Specialties
Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost Benefits
This study evaluates new contrast-derived indices of coronary microvascular function, highlighting their diagnostic potential and cost-effectiveness compared to traditional adenosine testing.
Dapagliflozin Shows Promising Benefits for Patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Landmark Multicentre Trial
Dapagliflozin significantly improves metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis outcomes without increasing adverse events, according to a rigorous 48-week randomized trial.
Posted inCritical Care news Specialties
Iloprost in Severe Septic Shock with Persistent Hypoperfusion: Insights from a Rigorous Randomized Trial
A recent double-blind RCT shows iloprost did not reduce organ failure severity in septic shock patients with persistent hypoperfusion, highlighting challenges in improving outcomes despite theoretical benefits in microcirculation.
The Microcirculation in Pregnancy: Guardian of Health or Victim of Preeclampsia?
This article explores how microcirculation functions as a key regulator in normal pregnancy but is compromised in preeclampsia, revealing early hemodynamic mechanisms behind gestational hypertension.